- $315.99m
- $1.24bn
- $0.89m
ProKidney tumbles on $125 mln public, direct stock offerings
U.S. STOCKS ON THE MOVE-FuelCell Energy, Copper miners , Apollo Global Management
U.S. STOCKS ON THE MOVE-PG&E, ICC Holdings, Krispy Kreme
U.S. STOCKS ON THE MOVE-Walmart, GameStop, Moderna
ProKidney jumps on positive mid-stage data for therapy
ProKidney Corp reports results for the quarter ended in March - Earnings Summary
ProKidney Corp expected to post a loss of 18 cents a share - Earnings Preview
ProKidney Corp expected to post a loss of 18 cents a share - Earnings Preview
Brief: ProKidney Announces Key Leadership Appointments Strengthening Clinical and Technical Operations
ProKidney Corp expected to post a loss of 17 cents a share - Earnings Preview
ProKidney Corp expected to post a loss of 17 cents a share - Earnings Preview
ProKidney Corp expected to post a loss of 17 cents a share - Earnings Preview
Brief: ProKidney Says Co May Offer And Sell Shares Of Its Class A Ordinary Shares
Brief: ProKidney Corp Says On Nov 28, Notified Deepak Jain, Chief Operating Officer Of Co Of Termination Of His Employment Without Cause
Brief: Prokidney Files For Mixed Shelf Offering Of $500 Mln
Brief: Chamath Palihapitiya Reports 4.5% Stake In Prokidney Corp
Brief: Prokidney Entered Into Share Repurchase Agreement With SC Pipe Holdings And SC Master Holdings
U.S. RESEARCH ROUNDUP-Beauty Health, Design Therapeutics, Energizer Holdings
Brief: ProKidney Q3 Operating Income USD -46.617 Million